Melbourne Clinical Trials
The Capsule Study
The purpose of this study is to evaluate a new drug that is hoped to be a new treatment for nonalcoholic fatty liver disease (NAFLD) and diabetes with NAFLD.
11 nights
1 visits
The number of patients with both Type 2 Diabetes and NAFLD is also gradually increasing. The way in which NAFLD and Type 2 Diabetes are triggered is not fully understood, but there is an increasing need for new and effective treatment of these conditions.
In this study you will receive a single dose of the medication via an oral capsule.
The trial has been approved by an independent ethics committee and participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males or females
Age 18 - 55 years old
BMI 18 - 32 kg/m²
Medication Not taking any medication
Medical History No significant medical history
Smoking History Non-smokers and casual smokers only (<10 cigarettes per week)